• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Motley Fool - Will 2016 Be Novartis' Worst Year Yet?





Simply riveting. Someone telling us what we already know.

I think we all expect this to be a rough year. But even this article discussed the potential for better performance in 2017 and beyond.

Sorry, I tried not to yawn over this but it was just such a predictable post.